Patent applications and USPTO patent grants for 2seventy bio, Inc..The latest application filed is for "compositions and methods for treating cancer".
Patent | Date |
---|---|
Compositions And Methods For Treating Cancer App 20220280567 - FRIEDMAN; KEVIN | 2022-09-08 |
Cd79b Chimeric Antigen Receptors App 20220226374 - FRIEDMAN; Kevin ;   et al. | 2022-07-21 |
Multivalent Chimeric Antigen Receptor App 20220218745 - POGSON; MARK | 2022-07-14 |
BCMA chimeric antigen receptors Grant 11,382,965 - Morgan , et al. July 12, 2 | 2022-07-12 |
Manufacturing Anti-bcma Car T Cells App 20220195060 - FRIEDMAN; Kevin ;   et al. | 2022-06-23 |
Salvage Chimeric Antigen Receptor Systems App 20220195039 - LEUNG; Wai-Hang | 2022-06-23 |
PD-1 homing endonuclease variants, compositions, and methods of use Grant 11,365,226 - Mann , et al. June 21, 2 | 2022-06-21 |
TCRa HOMING ENDONUCLEASE VARIANTS App 20220186198 - JARJOUR; Jordan ;   et al. | 2022-06-16 |
Pdcd-1 Homing Endonuclease Variants App 20220177860 - JARJOUR; JORDAN ;   et al. | 2022-06-09 |
BCMA chimeric antigen receptors Grant 11,351,236 - Morgan , et al. June 7, 2 | 2022-06-07 |
Homing Endonuclease Variants App 20220119784 - JARJOUR; JORDAN ;   et al. | 2022-04-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.